Stocktoria
electroCore, Inc. ECOR
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2018-06-22
electroCore, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $32.0M | $25.2M | $16.0M | $8.6M | $5.5M |
| Gross profit | $27.8M | $21.4M | $13.2M | $7.0M | $4.1M |
| R&D expense | — | $2.4M | $5.3M | $5.5M | $2.5M |
| SG&A expense | $38.2M | $31.2M | $27.2M | $24.3M | $21.6M |
| Operating income | -$13.2M | -$12.2M | -$19.3M | -$22.9M | -$20.0M |
| Interest expense | $14,900 | $18,400 | — | $4,000 | — |
| Income tax | $3,000 | -$93,000 | -$186,000 | -$431,000 | -$851,000 |
| Net income | -$14.0M | -$11.9M | -$18.8M | -$22.2M | -$17.2M |
| EPS (diluted) | $-1.65 | $-1.59 | $-3.42 | $-4.69 | $-4.36 |
| Operating cash flow | $8.2M | -$6.9M | $14.7M | -$16.6M | -$13.6M |
| Free cash flow | $8.1M | — | $14.5M | — | — |
| Cash & equivalents | $7.0M | $3.7M | $10.3M | $17.7M | $34.7M |
| Inventory | $1.6M | $1.7M | $2.2M | $2.0M | $1.4M |
| Total assets | $18.7M | $20.5M | $16.1M | $24.8M | $42.8M |
| Total liabilities | $20.4M | $12.9M | $8.7M | $7.7M | $6.2M |
| Shareholders' equity | -$1.7M | $7.5M | $7.4M | $17.1M | $36.6M |
Source: SEC EDGAR filings · CIK 0001560258 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.